Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.4% beneficial ownership stake in Infinity Natural Resources, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.1% beneficial ownership stake in INSMED INC as of June 30, 2025, primarily for investment purposes.

BlackRock, Inc. has filed an Amendment No. 17 to Schedule 13G, reporting a 13.2% beneficial ownership stake in Integra LifeSciences Holdings Corp, totaling 10,282,705 common shares as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 27,384,813 shares, representing 44.7% of the Common Stock of ISHARES GLOBAL 100 ETF.

BlackRock, Inc. has reported a 25.3% beneficial ownership stake, comprising 9,132,806 shares, in the iShares Europe ETF.

BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reaffirming its beneficial ownership of 10.6% in the iShares Global Consumer Staples ETF.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 14.5% beneficial ownership stake in Jack in the Box Inc. common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 14.8% beneficial ownership stake in Kohl's Corp common stock.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.4% of Kopin Corporation's common stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.4% beneficial ownership stake in Kymera Therapeutics, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 16.8% beneficial ownership stake in LXP Industrial Trust's common stock, held for passive investment purposes.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in Liberty Broadband Corp's Class A Stock, held for passive investment purposes.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 1.7% of Lightwave Logic, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has disclosed a 9.0% beneficial ownership stake in MGIC Investment Corporation, holding 21,404,266 common shares as a passive investor.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.7% beneficial ownership stake in MGM Resorts International's common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 2.9% beneficial ownership stake in MacroGenics Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 22 to Schedule 13G, reporting a 10.2% beneficial ownership stake in Manhattan Associates Inc., totaling 6,182,552 common shares.

BlackRock, Inc. has filed an Amendment No. 18 to Schedule 13G, disclosing a 13.3% beneficial ownership stake in Mercury Systems Inc. common stock as of June 30, 2025.

BlackRock, Inc. has reported a 6.2% beneficial ownership stake in Motorcar Parts America Inc., holding 1,208,730 common shares as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.7% of New Fortress Energy Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has reported a 5.0% beneficial ownership stake in Idaho Strategic Resources, Inc., holding 704,941 shares of common stock as of June 30, 2025.

BlackRock, Inc. has disclosed an increased beneficial ownership of 15.3% in New York Mortgage Trust Inc.'s common stock, holding over 13.8 million shares.

BlackRock, Inc. has reported a significant beneficial ownership stake of 5.3% in Oruka Therapeutics, Inc., totaling 1,988,880 shares of common stock.

BlackRock, Inc. has reported a 5.5% beneficial ownership stake in medical technology company Outset Medical, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.9% passive beneficial ownership stake in Ovid Therapeutics Inc. as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 14 to its Schedule 13G, disclosing a 9.0% beneficial ownership stake in PVH Corp. as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 11 to Schedule 13G, disclosing a beneficial ownership of 7.2% in Progressive Corp's common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.0% of Tango Therapeutics, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 5.3% of Jade Biosciences, Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.4% of Calumet, Inc.'s common stock as of June 30, 2025.